Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Ao‐Ji Xie, Elizabeth Ensink, Peipei Li, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1644-1653
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The gut-brain vascular axis in neuroinflammation
Sara Carloni, María Rescigno
Seminars in Immunology (2023) Vol. 69, pp. 101802-101802
Open Access | Times Cited: 59
Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study
Dong Ji, Wen-Zhu Chen, Lei Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 51
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Redox Biology (2024) Vol. 71, pp. 103092-103092
Open Access | Times Cited: 33
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 46
Fecal Microbiota Transplantation for Treatment of Parkinson Disease
Filip Scheperjans, Reeta Levo, Berta Bosch, et al.
JAMA Neurology (2024) Vol. 81, Iss. 9, pp. 925-925
Closed Access | Times Cited: 15
Diet and the gut microbiome in patients with Parkinson’s disease
Dayoon Kwon, Keren Zhang, Kimberly C. Paul, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis
Jake Boles, Maeve E. Krueger, Janna Jernigan, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 473-492
Open Access | Times Cited: 11
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Alejandro Borrego-Ruiz, Juan J. Borrego
Experimental Gerontology (2024) Vol. 194, pp. 112497-112497
Open Access | Times Cited: 11
Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
The gut microbiota-immune-brain axis: Therapeutic implications
Kenneth J. O’Riordan, Gerard M. Moloney, Lily Keane, et al.
Cell Reports Medicine (2025), pp. 101982-101982
Open Access | Times Cited: 1
Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic
Wen-Xiang Duan, Fen Wang, Junyi Liu, et al.
Neuroscience Bulletin (2023) Vol. 40, Iss. 4, pp. 500-516
Open Access | Times Cited: 22
Epigenetic effects of short-chain fatty acids from the large intestine on host cells
Richard A. Stein, Leise Riber
microLife (2023) Vol. 4
Open Access | Times Cited: 21
Butyrate as a potential therapeutic agent for neurodegenerative disorders
Prapti Chakraborty, Hasinika K. A. H. Gamage, Angela S. Laird
Neurochemistry International (2024) Vol. 176, pp. 105745-105745
Closed Access | Times Cited: 7
Characteristics of Oral-Gut Microbiota in Model Rats with CUMS-Induced Depression
Yan Li, Penghong Liu
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 221-232
Open Access | Times Cited: 6
The pathobiological basis of depression in Parkinson disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 12, pp. 1397-1418
Open Access | Times Cited: 27
The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
Qing Li, Ling‐bing Meng, Lijun Chen, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 16
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
Shabnam Nohesara, Hamid M. Abdolmaleky, Jin‐Rong Zhou, et al.
Genes (2023) Vol. 14, Iss. 12, pp. 2217-2217
Open Access | Times Cited: 13
N6 methyladenosine eraser FTO suppresses Staphylococcus aureus‐induced ferroptosis of bone marrow mesenchymal stem cells to ameliorate osteomyelitis through regulating the MDM2/TLR4/SLC7A11 signaling pathway
Muguo Song, Kehan Lv, Xu Zhi, et al.
Cell Biology International (2024) Vol. 48, Iss. 4, pp. 450-460
Closed Access | Times Cited: 5
Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review
Caroline Fussing Bruun, Tue H. Hansen, Maj Vinberg, et al.
Nutritional Neuroscience (2023) Vol. 27, Iss. 8, pp. 899-912
Closed Access | Times Cited: 12
The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson’s disease
Zihao Wang, Huan Xia, Tingting Feng, et al.
Neurological Sciences (2024) Vol. 45, Iss. 8, pp. 3809-3815
Closed Access | Times Cited: 4
An Overview of Epigenetic Changes in the Parkinson’s Disease Brain
Anthony Klokkaris, Anna Migdalska‐Richards
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6168-6168
Open Access | Times Cited: 4
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Dayamrita Kollaparampil Kishanchand, Athira Krishnan K. A., Krishnapriya Chandrababu, et al.
Journal of Neuroscience Research (2025) Vol. 103, Iss. 1
Closed Access
Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion
Maeve E. Krueger, Jake Boles, Zachary D. Simon, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
A Comparative Analysis of the Gut Microbiota in Patients With Parkinson’s Disease Worldwide: A Systematic Review
М.Б. Бейсембаева, Yelena Shayakhmetova, Shynar Muratbekova, et al.
International Journal of Clinical Practice (2025) Vol. 2025, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top